◆英語タイトル:Kuros Biosciences Ltd (KURN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011149
◆発行会社(調査会社):
GlobalData
◆発行日:2017年12月21日
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Kuros Biosciences Ltd (Kuros Biosciences) is a biotechnology company that develops products for tissue repair and regeneration. It develops a family of bone healing products to address indications in trauma and spine called orthobiologics. It is focused on bone repair for trauma, specifically fracture repair, as well as on spinal fusion. Its pipeline of products includes MagnetOs Granules, MagnetOs Putty, KUR-111, KUR-113 and KUR-112. Kuros Biosciences uses a synthetic matrix technology with reliable and pressure resistant, rapid closure of the damaged tissues. The company’s lead sealant product is Neuroseal (KUR-023) developed as an adjunct to suturing for sealing of the dura after cranial surgery. Kuros Biosciences is headquartered in Schlieren, Switzerland.
Kuros Biosciences Ltd (KURN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Kuros Biosciences Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Kuros Biosciences Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Kuros Biosciences Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Kuros Biosciences Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Kuros Biosciences Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Kuros Biosciences Ltd, Medical Equipment, Deal Details 10
Venture Financing 10
Kuros Biosurgery Raises Additional USD5 Million Financing 10
Kuros Biosurgery Raises USD15.34 Million in Venture Financing 11
Merger 12
Cytos Biotech Merges with Kuros Biosurgery 12
Equity Offering 13
Kuros Biosciences to Raise up to USD30.2 Million in Private Placement of Shares 13
Kuros Biosciences Raises Funds through Rights Offering of Shares 14
Kuros Biosciences Raises Funds through Public Offering of Shares 15
Acquisition 16
Kuros Biosciences to Acquire Xpand Biotech 16
Kuros Biosciences Ltd – Key Competitors 17
Kuros Biosciences Ltd – Key Employees 18
Kuros Biosciences Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
Apr 26, 2017: Kuros Biosciences Reports Financial Results for 2016 20
Sep 29, 2016: Kuros Biosciences Reports Financial Results for First Half-Year of 2016 22
Apr 26, 2016: Kuros Biosciences Reports Financial Results for 2015 24
Corporate Communications 25
Dec 14, 2017: Kuros Biosciences Announces Management Succession 25
Nov 28, 2017: Kuros Biosciences’ Chief Medical Officer to Retire 26
Nov 16, 2017: Kuros announces management changes 27
Apr 28, 2017: Kuros Biosciences Proposes Election of Four New Board Members 28
Apr 13, 2017: Kuros announces CEO succession 29
Aug 10, 2016: Kuros appoints Philippe Saudan as Chief Development Officer 30
Mar 08, 2016: Kuros Biosciences appoints Chief Medical Officer 31
Legal and Regulatory 32
Feb 08, 2017: Kuros achieves ISO certification for surgical sealants 32
Jan 08, 2016: Cytos Biotechnology will be renamed Kuros Biosciences 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34
List of Tables
Kuros Biosciences Ltd, Medical Equipment, Key Facts, 2016 2
Kuros Biosciences Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Kuros Biosciences Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Kuros Biosciences Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Kuros Biosciences Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Kuros Biosciences Ltd, Deals By Market, 2011 to YTD 2017 8
Kuros Biosciences Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Kuros Biosurgery Raises Additional USD5 Million Financing 10
Kuros Biosurgery Raises USD15.34 Million in Venture Financing 11
Cytos Biotech Merges with Kuros Biosurgery 12
Kuros Biosciences to Raise up to USD30.2 Million in Private Placement of Shares 13
Kuros Biosciences Raises Funds through Rights Offering of Shares 14
Kuros Biosciences Raises Funds through Public Offering of Shares 15
Kuros Biosciences to Acquire Xpand Biotech 16
Kuros Biosciences Ltd, Key Competitors 17
Kuros Biosciences Ltd, Key Employees 18
Kuros Biosciences Ltd, Subsidiaries 19